Ketamine enantiomers differentially relax isolated coronary artery rings

Eur J Anaesthesiol. 2005 Mar;22(3):215-21. doi: 10.1017/s0265021505000372.

Abstract

Background and objective: It has been shown that racemic ketamine increases coronary blood flow and that this effect is at least in part due to a direct vasorelaxing effect of this substance. This study was designed to determine whether ketamine might stereoselectively relax isolated porcine coronary arteries.

Methods: Using the model of isolated vessels we studied the effects of S(+) ketamine, R(-) ketamine, and racemic ketamine (5-500 microg mL(-1)) on artery strips pre-contracted by either potassium chloride (KCl) or prostaglandin F2alpha (PGF2alpha). To elucidate possible mechanisms of action these experiments were repeated in the presence of one of the following compounds: N(omega)-nitro-L-arginine (L-NNA), indomethacin, glibenclamide, and tetraethylammonium (TEA) chloride, an inhibitor of the BK(Ca) K+ channel.

Results: Both isoforms and racemic ketamine relaxed isolated coronary arteries in a concentration-dependent manner in concentrations beyond those used in clinical practice. S(+) ketamine exerted the strongest vasorelaxing effect, followed by racemic ketamine and R(-) ketamine. Pretreatment with L-NNA, indomethacin, or glibenclamide did not alter the vasodilating properties of ketamine, whereas TEA chloride significantly attenuated the vasorelaxing effects of all the three forms of ketamine.

Conclusions: Ketamine dilates coronary arteries in vitro when administered in high concentrations. There is a stereoselective difference with a stronger vasorelaxing effect of S(+) ketamine compared to racemic and R(-) ketamine. The impact of TEA chloride suggests that the activation of the BK(Ca) channel may contribute to the vasodilating effect of ketamine.

MeSH terms

  • Anesthetics, Dissociative / administration & dosage
  • Anesthetics, Dissociative / pharmacology*
  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • Cardiovascular Agents / pharmacology
  • Coronary Vessels / drug effects*
  • Dinoprost / pharmacology
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Glyburide / pharmacology
  • Indomethacin / pharmacology
  • Ketamine / administration & dosage
  • Ketamine / pharmacology*
  • Nitroarginine / pharmacology
  • Potassium Channel Blockers / pharmacology
  • Potassium Chloride / pharmacology
  • Stereoisomerism
  • Swine
  • Tetraethylammonium / pharmacology
  • Vasoconstrictor Agents / pharmacology
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / pharmacology*

Substances

  • Anesthetics, Dissociative
  • Anti-Arrhythmia Agents
  • Cardiovascular Agents
  • Enzyme Inhibitors
  • Potassium Channel Blockers
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Nitroarginine
  • Tetraethylammonium
  • Potassium Chloride
  • Ketamine
  • Dinoprost
  • Glyburide
  • Indomethacin